Researchers at the US National Institutes of Health have discovered that small doses of aspirin can increase the chances of overcoming cancer.
According to the JAMA Network, researchers studied data for 140,000 American citizens collected during 12.5 years, and discovered that those who took aspirin from one to three times a week had a death rate among them after developing prostate, colon, rectal, or lung cancer, or Ovarian is less than those who did not use it for treatment.
But according to researchers, this matter is only observed in people whose weight was normal, as this was not observed in those who are underweight or overweight.
The researchers also recognized the need for new research in order to discover the relationship between aspirin dose size and body mass index and the effectiveness of this drug in preventing cancer.
The researchers also recognized the need for new research in order to discover the relationship between aspirin dose size and body mass index and the effectiveness of this drug in preventing cancer.
It is reported that scientists are again starting to care about aspirin and other drugs based on salicylic acid, which, as experiments have shown, have strong anti-cancer properties. According to experts and doctors, aspirin can increase the effectiveness of immunotherapy, and fight leukemia, colon and many other tumors, which increases the chances of survival after chemotherapy by 15-20%.
On the other hand, many responsible agencies, including the FDA in the United States, prohibit the use of aspirin because it may cause bleeding and stroke and exacerbate ulcers, because one of its properties is to dissolve blood clots in the blood vessels of the brain and intestine.